| 000 | 01275 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250513141122.0 | ||
| 264 | 0 | _c19980428 | |
| 008 | 199804s 0 0 eng d | ||
| 022 | _a0895-4356 | ||
| 024 | 7 |
_a10.1016/s0895-4356(97)00289-8 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKramer, M S | |
| 245 | 0 | 0 |
_aAminorex, dexfenfluramine, and primary pulmonary hypertension. _h[electronic resource] |
| 260 |
_bJournal of clinical epidemiology _cApr 1998 |
||
| 300 |
_a361-4 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAminorex _xadverse effects |
| 650 | 0 | 4 |
_aAppetite Depressants _xadverse effects |
| 650 | 0 | 4 |
_aEurope _xepidemiology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFenfluramine _xadverse effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypertension, Pulmonary _xchemically induced |
| 650 | 0 | 4 | _aIncidence |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aObesity _xdrug therapy |
| 650 | 0 | 4 | _aOdds Ratio |
| 650 | 0 | 4 | _aPharmacoepidemiology |
| 650 | 0 | 4 | _aPrevalence |
| 700 | 1 | _aLane, D A | |
| 773 | 0 |
_tJournal of clinical epidemiology _gvol. 51 _gno. 4 _gp. 361-4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0895-4356(97)00289-8 _zAvailable from publisher's website |
| 999 |
_c9507395 _d9507395 |
||